Related Experiment Videos
[Visual evoked potentials in Creutzfeldt-Jakob disease].
J Spiegel1, G Fuss, U Dillmann
1Neurologische Klinik, Universitätskliniken des Saarlandes, Homburg/Saar, Germany.
Der Nervenarzt
|October 12, 2002
Summary
Visual evoked potentials (VEP) reveal early visual system dysfunction in Creutzfeldt-Jakob disease (CJD) patients, even before vision loss is clinically apparent. These findings highlight VEP as a sensitive tool for detecting subclinical neurological effects in early-stage CJD.
Area of Science:
- Neuroscience
- Ophthalmology
- Neurology
Context:
- Creutzfeldt-Jakob disease (CJD) neuropathology frequently impacts the visual system.
- Clinical vision deterioration is not universally reported in CJD patients.
- Understanding early CJD effects on vision is crucial for diagnosis and management.
Purpose:
- To investigate visual system function in sporadic CJD using visual evoked potentials (VEP).
- To determine if VEP abnormalities correlate with clinical visual deficits in CJD.
- To assess the utility of VEP in detecting early-stage visual system involvement in CJD.
Summary:
- Monocular pattern-reversal VEP were recorded in six sporadic CJD patients (1-13 months post-symptom onset).
- All patients exhibited pathological VEP findings, including delayed P100 components or loss of cortical response.
- VEP abnormalities were present regardless of whether patients reported visual impairment, indicating early subclinical effects.
Impact:
- VEP testing can detect early, subclinical visual system dysfunction in CJD.
- VEP may serve as a valuable diagnostic biomarker in the initial stages of CJD.
- These findings underscore the sensitivity of VEP in identifying neurological impact in CJD, irrespective of overt symptoms.